Subconjunctival bevacizumab for corneal neovascularization

被引：0
|
作者：
Mesut Erdurmus
Yuksel Totan
机构：
[1] Fatih University Medical School,Department of Ophthalmology
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2007年 / 245卷
关键词：
Bevacizumab; Corneal neovascularization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1577 / 1579
页数：2
相关论文
共 50 条
  • [31] Effects of Subconjunctival Tocilizumab Versus Bevacizumab in Treatment of Corneal Neovascularization in Rabbits
    Yoo, Ae Ri
    Chung, Sung Kun
    CORNEA, 2014, 33 (10) : 1088 - 1094
  • [32] Clinico-biochemical Correlation of the Effect of Subconjunctival Bevacizumab for Corneal Neovascularization
    Agarwal, Shweta
    Angayarkanni, Narayanasamy
    Iyer, Geetha
    Srinivasan, Bhaskar
    Natarajan, Radhika
    Charola, Sanket
    Arumugam, Sumathi
    Padmanabhan, Prema
    CORNEA, 2014, 33 (10) : 1016 - 1021
  • [33] Inhibition of Corneal Neovascularization by Subconjunctival and Topical Bevacizumab and Sunitinib in a Rabbit Model
    Ko, Byung-Yi
    Kim, Young-sung
    Baek, Sung-gook
    Lee, Gun-woong
    Kim, Jae-Min
    Jean, Woo-Sean
    Lee, Nam-Seob
    Kang, Jaeku
    CORNEA, 2013, 32 (05) : 689 - 695
  • [34] Subconjunctival Injection of Bevacizumab in the Treatment of Corneal Neovascularization Associated With Lipid Deposition
    Chu, Hsiao-Sang
    Hu, Fung-Rong
    Yang, Chung-May
    Yeh, Po-Ting
    Chen, Yan-Ming
    Hou, Yu-Chih
    Chen, Wei-Li
    CORNEA, 2011, 30 (01) : 60 - 66
  • [35] Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin)
    Kim, Tae-im
    Kim, Sang Woo
    Kim, Sunwoong
    Kim, Terry
    Kim, Eung Kweon
    CORNEA, 2008, 27 (03) : 349 - 352
  • [36] Subconjunctival Injection of Bevacizumab (Avastin) on Corneal Neovascularization in Different Rabbit Models of Corneal Angiogenesis
    Chen, Wei-Li
    Lin, Chung-Tien
    Lin, Nien-Ting
    Tu, I-Hua
    Li, Jing-Wen
    Chow, Lu-Ping
    Liu, Kwan-Rong
    Hu, Fung-Rong
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (04) : 1659 - 1665
  • [37] Efficacy of Subconjunctival Aflibercept Versus Bevacizumab for Prevention of Corneal Neovascularization in a Rat Model
    Gal-Or, Orly
    Livny, Eitan
    Sella, Ruti
    Nisgav, Yael
    Weinberger, Dov
    Livnat, Tami
    Bahar, Irit
    CORNEA, 2016, 35 (07) : 991 - 996
  • [38] Recurrence of Corneal Neovascularization Associated With Lipid Deposition After Subconjunctival Injection of Bevacizumab
    Chu, Hsiao-Sang
    Chen, Ta-Ching
    Hu, Fung-Rong
    Chen, Wei-Li
    CORNEA, 2013, 32 (11) : 1446 - 1453
  • [39] The effect of subconjunctival bevacizumab on corneal neovascularization, inflammation and re-epithelization in a rabbit model
    Mello, Glauco Reggiani
    Pizzolatti, Marcos Longo
    Wasilewski, Daniel
    Santhiago, Marcony R.
    Budel, Vinicius
    Moreira, Hamilton
    CLINICS, 2011, 66 (08) : 1443 - 1449
  • [40] Effect of subconjunctival bevacizumab on corneal neovascularization and reepithelization 25 days after chemical burn
    Reggiani Mello, Glauco Henrique
    Lupion, Fabiola Grigoletto
    Oliveira, Fernanda Moreira
    Bude, Lucas Roskamp
    Wasileweski, Daniel
    Cavalcanti, Teresa Cristina
    Moreira, Hamilton
    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2011, 74 (01) : 48 - 52
12345